エンセファロパシー(脳障害):グローバル臨床試験動向(2014年上半期)...市場調査レポートについてご紹介

【英文タイトル】Encephalopathy Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Encephalopathy 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Encephalopathy to Central Nervous System Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Encephalopathy to Central Nervous System Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Encephalopathy 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Encephalopathy Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Hamad Medical Corporation 30
Clinical Trial Overview of Hamad Medical Corporation 30
GlaxoSmithKline plc 31
Clinical Trial Overview of GlaxoSmithKline plc 31
Clinical Trial Overview of Top Institutes / Government 32
Eunice Kennedy Shriver National Institute of Child Health and Human Development 32
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 32
University College London 33
Clinical Trial Overview of University College London 33
University of Tanta 34
Clinical Trial Overview of University of Tanta 34
University of California, San Francisco 35
Clinical Trial Overview of University of California, San Francisco 35
Johns Hopkins University 36
Clinical Trial Overview of Johns Hopkins University 36
Vanderbilt University 37
Clinical Trial Overview of Vanderbilt University 37
University Hospital Basel 38
Clinical Trial Overview of University Hospital Basel 38
Columbia University 39
Clinical Trial Overview of Columbia University 39
The National Institute of Allergy and Infectious Diseases 40
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 40
Children’s Hospital of Fudan University 41
Clinical Trial Overview of Children’s Hospital of Fudan University 41
Five Key Clinical Profiles 42
Appendix 62
Abbreviations 62
Definitions 62
Research Methodology 63
Secondary Research 63
About GlobalData 64
Contact Us 64
Disclaimer 64
Source 64


【レポート販売概要】

■ タイトル:エンセファロパシー(脳障害):グローバル臨床試験動向(2014年上半期)
■ 英文:Encephalopathy Global Clinical Trials Review, H1, 2014
■ 発行日:2014年6月30日
■ 調査会社:GlobalData
■ 商品コード:GDHC2220CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。